Default: Journal of Heart and Lung Transplantation

ISSN: 1053-2498

Journal Home

Journal Guideline

Journal of Heart and Lung Transplantation Q1 Unclaimed

Elsevier USA United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Heart and Lung Transplantation is a journal indexed in SJR in Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine with an H index of 135. It has an SJR impact factor of 3,549 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,549.

Journal of Heart and Lung Transplantation focuses its scope in these topics and keywords: heart, transplantation, lung, pulmonary, arterial, transplant, society, international, injury, disease, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Metrics

Journal of Heart and Lung Transplantation

3,549

SJR Impact factor

135

H Index

1537

Total Docs (Last Year)

645

Total Docs (3 years)

4734

Total Refs

3313

Total Cites (3 years)

371

Citable Docs (3 years)

4,74

Cites/Doc (2 years)

3,08

Ref/Doc

Aims and Scope


heart, transplantation, lung, pulmonary, arterial, transplant, society, international, injury, disease, allograft, survival, consensus, fontanassociated, formulation, congenital, comparison, advanced, anatomic, biopsy, candidates, cardiac, cardiopulmonary, chronic, circulatory, classificationthe, clinical,



Best articles by citations

Cardiac transplantation in patients with refractory ventricular arrhythmias11The authors wish to thank Tim Furlong for expert secretarial assistance in the preparation of this manuscript.

View more

The significance of HLA matching in cardiac transplantation

View more

Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration

View more

Arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats

View more

Pediatric arterio-venous extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation

View more

Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation

View more

Lung transplantation in a Jehovah's Witness

View more

Selection and management of ventricular assist device patients: the Muenster experience

View more

The effect of race on beta-adrenergic receptor density

View more

The effect of short-term coronary perfusion using a perfusion apparatus on canine heart transplantation from non-heart-beating donors

View more

Genetic variations of the apolipoprotein E gene determine the plasma triglyceride levels after heart transplantation

View more

Hepatitis C transmission and infection by orthotopic heart transplantation

View more
SHOW MORE ARTICLES

Phospholipase A2 inhibitor attenuates NOx production and myocardial damage in the cardiac allograft

View more

Accelerated cardiac allograft rejection with apoptosis and complement deposition in Fc receptor null mice

View more

Use of donor hearts with coronary artery disease

View more

Behavioral and environmental factors contributing to the development and progression of congestive heart failure11The author wishes to thank Tim Furlong for excellent secretarial assistance in the preparation of this manuscript.

View more

Who should be transplanted with HLHS? Few patient related factors alter outcome following stage I reconstruction

View more

Sudden death in heart failure patients: effects of optimized medical therapy

View more

IL-4 receptora gene polymorphism in heart transplantation

View more

Reduced size lung transplantation - technique and results

View more

Increased expression of a spliced isoform of serum response factor contributes to DYS-regulation of myocardial gene expression during heart failure

View more

Endothelial MHC-I-peptides specificity in IFN-gamma induced cytoprotection against natural killing

View more

Preservation of the lung with LPD solution - one year of follow up

View more

Calcium channel blockers and angiotensin-converting enzyme inhibitors in the prevention of graft vasculopathy

View more

Comments

No comments ... Be the first to comment!

FAQS